Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 17;12(4):e8802.
doi: 10.1002/ccr3.8802. eCollection 2024 Apr.

Comment on case of benralizumab-induced exacerbations of chronic spontaneous urticaria

Affiliations

Comment on case of benralizumab-induced exacerbations of chronic spontaneous urticaria

Mustafa Ilker Inan et al. Clin Case Rep. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Similar articles

References

    1. Magen E, Komarova I, Magen I, Phirtskhalava S. Case of benralizumab‐induced exacerbations of chronic spontaneous urticaria. Clin Case Rep. 2022;10(6):e05930. doi:10.1002/ccr3.5930 - DOI - PMC - PubMed
    1. 2023 GINA Main Report. Available from: https://ginasthma.org/wp‐content/uploads/2023/07/GINA‐2023‐Full‐report‐2....
    1. Nagase H, Suzukawa M, Oishi K, Matsunaga K. Biologics for severe asthma: the real‐world evidence, effectiveness of switching, and prediction factors for the efficacy. Allergol Int. 2023;72(1):11‐23. doi:10.1016/j.alit.2022.11.008 - DOI - PubMed
    1. Akenroye AT, Segal JB, Zhou G, et al. Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: a target trial emulation. J Allergy Clin Immunol. 2023. May;151(5):1269‐1276. - PMC - PubMed
    1. Maurer M, Khan DA, Elieh Ali Komi D, Kaplan AP. Biologics for the use in chronic spontaneous urticaria: when and which. J Allergy Clin Immunol Pract. 2021;9(3):1067‐1078. doi:10.1016/j.jaip.2020.11.043 - DOI - PubMed

LinkOut - more resources

-